Journal Mobile Options
Table of Contents
Vol. 64, No. 2, 2007
Issue release date: August 2007
Gynecol Obstet Invest 2007;64:65–68
(DOI:10.1159/000099149)

Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes

D’Anna R. · Baviera G. · Cannata M.L. · De Vivo A. · Di Benedetto A. · Corrado F.
Departments of aObstetrics and Gynecology and bInternal Medicine, University of Messina, Messina, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Aims: To evaluate midtrimester amniotic fluid leptin levels in pregnancies subsequently complicated by gestational diabetes. Methods: We studied 32 pregnant women with gestational diabetes and a control group of 43 normal pregnancies with an adequate gestational age fetus. All underwent a midtrimester amniocentesis: leptin and insulin were measured in the amniotic fluid. Data were compared with the Mann-Whitney U-test. Results: Median leptin concentrations in the amniotic fluid of the gestational diabetes mellitus patients were significantly higher than in the control group (15.1 vs. 7.9 ng/ml) (p = 0.001); amniotic insulin concentrations were also higher in the gestational diabetes mellitus than in the control group (0.67 vs. 0.38 µU/ml) (p = 0.02). Furthermore, amniotic fluid leptin levels were directly correlated with amniotic insulin concentrations; instead, there was no correlation with maternal BMI and birth weight. Conclusion: Our data suggest that in pregnancies subsequently complicated by gestational diabetes, amniotic fluid leptin and insulin levels are higher in the early fetal period.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold R, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.
  2. Halaas JL, Gajiwala KS, Maffei M, et al: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543–546.
  3. Henson MC, Castracane VD: Leptin in pregnancy. Biol Reprod 2000;63:1219–1228.
  4. Kautzki-Willer A, Pacini G, Tura A, et al: Increased plasma leptin in gestational diabetes. Diabetologia 2001;44:164–172.
  5. Tapanainen P, Leinonen E, Ruokonen A, Knip L: Leptin concentrations are elevated in newborn infants of diabetic mothers. Horm Res 2001;55:185–190.
  6. Okereke NC, Uvena-Celebrezze J, Hutson-Presley L, Amini SB, Catalano PM: The effect of gender and gestational diabetes mellitus on cord leptin concentration. Am J Obstet Gynecol 2002;187:798–803.
  7. Masuzaki H, Ogawa Y, Sagawa N, et al: Non-adipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997;3:1029–1033.
  8. Schubring C, Prohaska F, Prohaska A, et al: Leptin concentration in maternal serum and amniotic fluid during the second trimenon: differential relation to fetal gender and maternal morphometry. Eur J Obstet Gyencol Reprod Biol 1999;86:151–157.
  9. Schubring C, Kiess W, Englaro P, et al: Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endicrinol Metab 1997;82:1480–1483.
  10. Carpenter MW, Canick JA, Star JA, Carr SR, Burke ME, Shahinian K: Fetal hyperinsulinism at 14–20 weeks and subsequent gestational diabetes. Obstet Gynecol 1996;87:89–93.
  11. Carpenter MW, Coustan DR: Criteria for screening tests of gestational diabetes. Am J Obstet Gyencol 1982;144:768–773.
  12. Cagnacci A, Arangino S, Caretto S, Mazza V, Volpe A: Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation. Relation to fetal growth. Eur J Obstet Gynecol Reprod Biol 2006;124:53–57.
  13. Cetin I, Morpurgo PS, Radaelli T, et al: Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr Res 2000;48:646–651.
  14. Woelfer B, Hafner E, Metzenbauer M, Schuchter K, Philipp K: The influence of leptin on placental and fetal volume measured by three-dimensional ultrasound in the second trimester. Placenta 2005;26:124–128.
  15. Yura S, Sagawa N, Ogawa Y, et al: Augmentation of leptin synthesis and secretion through activation of protein kinases A and C in cultured human trophoblast cells. J Clin Endocrinol Metab 1998;83:3609–3614.
  16. Jansson N, Greenwood SL, Johansson BR, Powell TL, Jansson T: Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab 2003;88:1205–1211.
  17. Adam P, Teramo K, Raiha N, Gitlin D, Schwartz R: Human fetal insulin metabolism early in gestation: response to acute elevation of the fetal glucose concentration and placental transfer of human insulin-I-131. Diabetes 1969;18:409–416.
  18. Reiher H, Fuhrmann K, Niack S, Woltanski KP, Jutzi E, Hahn von Dorsche H, Hahn HJ: Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 1983;6:446–451.
  19. Kolaczynski J, Nyce M, Considine R, Boden G, Nolan J, Henry R, Mudaliar S, Olefsky J, Caro J: Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996;45:699–701.
  20. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, Hauguel-de Mouzon S: Overexpression of placental leptin in diabetic pregnancy. Diabetes 1998;47:847–850.
  21. Hoggard N, Haggarty P, Thomas L, Lea RG: Leptin expression in placental and fetal tissues: Does leptin have a functional role? Biochem Soc Trans 2001;29:57–63.
  22. Oktem O, Dedeoglu N, Oymak Y, et al: Maternal serum, amniotic fluid and cord leptin levels at term: their correlations with fetal weight. J Perinat Med 2004;32:266–271.
  23. Roig MDG, Sabrià J, Valls C, Borras M, Mirò E, Ponce J, Vicens JML: The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin-like growth factor I, leptin, and α-fetoprotein. Eur J Obstet Gynecol Reprod Biol 2005;120:27–32.
  24. Chan TF, Chung YF, Chen HS, Su JH, Yuan SS: Elevated amniotic fluid leptin levels in early second trimester are associated with earlier delivery and lower birth weight in twin pregnancy. Acta Obstet Gynecol Scand 2004;83:707–710.
  25. Basburg M, Serin IS, Ozcelik B, Kula M, Basburg EM, Tutus A: Correlation of elevated leptin levels in amniotic fluid and maternal serum in neural tube defects. Obstet Gynecol 2003;101:523–528.
  26. Carpenter MW, Canick JA, Hogan JW, Shellum C, Somers M, Star JA: Amniotic fluid insulin at 14–20 weeks’ gestation. Diabetes Care 2001;24:1259–1263.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00